Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/30/2003WO2003052142A3 Analysis and detection of multiple target sequences using circular probes
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003052059A3 Recombinant bovine thrombin
10/30/2003WO2003051388A3 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
10/30/2003WO2003051308A3 Antisense modulation of tfap2c expression
10/30/2003WO2003050233A3 Gene promoters
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046142A3 Methods for producing stocks of recombinant aav virions
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003037370A3 Anthrax antigenic compositions
10/30/2003WO2003035882A3 Novel expression system
10/30/2003WO2003035859A3 Regulation of human serine/threonine kinase
10/30/2003WO2003035849A3 Methods for gene transfer using pseudotyped lentiviruses
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003035692A3 Modified peptides and their uses
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003033703A3 Human gtp-activator protein for rab-like gtpase
10/30/2003WO2003031633A3 Adenoviral vector system
10/30/2003WO2003031612A3 Method for determining cell cycle position
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003031469A3 Means for improving immune response
10/30/2003WO2003029274A3 Paramyxoviruses as gene transfer vectors to lung cells
10/30/2003WO2003027311A3 A clone-array pooled shotgun strategy for nucleic acid sequencing
10/30/2003WO2003027241A3 Animal integration vector and methods for its use
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003026403A3 Ctsz disruptions, compositions and methods relating thereto
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003024200A3 Production of transgenic birds using stage x primordial germ cells
10/30/2003WO2003022040A3 Method for producing transgenic animals
10/30/2003WO2003020896A3 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
10/30/2003WO2003020879A3 Cells and methods for propagating adenoviral vectors
10/30/2003WO2003020415A3 Treatment of substrates using an electrochemical method
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018821A3 Compositions and methods for treating neurodegenerative diseases
10/30/2003WO2003018815A3 Regulation of human g protein-couple receptor kinase
10/30/2003WO2003018600A3 Antisense modulation of microsomal triglyceride transfer protein expression
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014310A3 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/30/2003WO2003014150A3 Fusion proteins for insect control
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003WO2003010335A3 Il-4 receptor sequence variation associated with type 1 diabetes
10/30/2003WO2003010333A3 Methods for gene disruption and uses thereof
10/30/2003WO2003010319A3 Transformation method for obtaining marker-free plants and plants obtained therewith
10/30/2003WO2003010312A3 Nucleic acid sequences encoding enantioselective amidases
10/30/2003WO2003008628A3 Enzymatic nucleic acid peptide conjugates
10/30/2003WO2003008618A3 Glucans and glucansucrases derived from lactic acid bacteria
10/30/2003WO2003008615A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene
10/30/2003WO2003008608A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phoe gene
10/30/2003WO2003008605A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced male gene
10/30/2003WO2003008593A3 A thermostable isomerase and use thereof in particular for producing tagatose
10/30/2003WO2003006648A3 S. pombe calnexin mutant strain
10/30/2003WO2003004698A3 Method for monitoring and modulating protein folding
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000728A3 Testis protein, zsig86
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002103042A3 Method and nucleic acids for the differentiation of prostate tumors
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002101012A3 Regulation of transgene expression following aav transduction
10/30/2003WO2002100530A3 Method for controlling fermentation
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002097390A3 A quantitative hybridization assay for the analysis of nucleic acid
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002095038A3 Vectors for enhanced expression of vegf for disease treatment
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002093519A3 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
10/30/2003WO2002086146A3 Synthetic nucleic acid molecule for imparting multiple traits
10/30/2003WO2002086122A3 Protein-protein interactions in adipocytes
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002083906A9 Mhc tetramers
10/30/2003WO2002081722A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene
10/30/2003WO2002081721A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene
10/30/2003WO2002081698A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated frur gene
10/30/2003WO2002080755A3 Kits and methods for assessing oxidative stress
10/30/2003WO2002079444A3 Transgenic mice containing msk2 serine/threonine kinase gene disruptions
10/30/2003WO2002074943A3 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains
10/30/2003WO2002074803A3 Regulation of human icos v protein
10/30/2003WO2002072881A3 Method for the amplification and detection of hbv dna using a transcription based amplification
10/30/2003WO2002072851A3 Lentiviral packaging constructs
10/30/2003WO2002072848A3 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
10/30/2003WO2002072758A3 Cytochrome p450s and uses thereof
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002068693A3 Method for the systematic discovery of genes and genes discovered thereby
10/30/2003WO2002068683A3 Circular probe amplification (cpa) using energy-transfer primers
10/30/2003WO2002068645A3 Compositions and methods relating to breast specific genes and proteins
10/30/2003WO2002068634A3 Method for producing gene libraries
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066637A8 Method for collecting and using nuclear mrna
10/30/2003WO2002066612A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002063030A3 Charge tags and separation of nucleic acid molecules
10/30/2003WO2002063024A3 Sustained totipotent culture of selected monocot genera
10/30/2003WO2002062986A8 Replicative in vivo gene targeting
10/30/2003WO2002062965A3 Method for identifying intercellular protein factors
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
1 ... 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 ... 4023